Optic nerve and optic radiation neurodegeneration in patients with glaucoma: in vivo analysis with 3-T diffusion-tensor MR imaging.

PURPOSE To evaluate, with high-field-strength diffusion-tensor (DT) magnetic resonance (MR) imaging, the axonal architecture of the optic nerves and optic radiations in patients with glaucoma and determine whether DT MR imaging-derived parameters correlate with disease severity. MATERIALS AND METHODS The study was approved by the institutional review board. All participants provided written informed consent. Sixteen patients with primary open-angle glaucoma were examined. Glaucoma severity was clinically assessed with use of a six-stage system based on static threshold visual field parameters. Ten healthy individuals served as control subjects. DT MR imaging was performed with a 3-T MR unit. Mean diffusivity (MD) and fractional anisotropy (FA) maps were automatically created. Regions of interest were positioned on the MD and FA maps, and mean MD and mean FA values were calculated for each optic nerve and each optic radiation. RESULTS The optic radiations and optic nerves of patients with glaucoma, as compared with control subjects, had significantly higher MD and significantly lower FA. The mean MD values for the optic nerves and the glaucoma stages varied consistently (r = 0.8087, P < .0001). A negative correlation between mean FA for the optic nerves and glaucoma stage (r = -0.7464, P < .0001) was observed. CONCLUSION Glaucoma is a complex neurologic disease that affects optic nerves and optic radiations. The finding that DT MR imaging-derived MD and FA in the optic nerves correlate with glaucoma severity suggests that these parameters could serve as complementary indicators of disease severity.

[1]  E. Wu,et al.  Diffusion Tensor MR Study of Optic Nerve Degeneration in Glaucoma , 2007, 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[2]  William H Swanson,et al.  Perimetric defects and ganglion cell damage: interpreting linear relations using a two-stage neural model. , 2004, Investigative ophthalmology & visual science.

[3]  R. Harwerth,et al.  Visual field defects and retinal ganglion cell losses in patients with glaucoma. , 2006, Archives of ophthalmology.

[4]  B. Chauhan Canadian Glaucoma Study: 1. Study design, baseline characteristics, and preliminary analyses. , 2006, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[5]  M R Symms,et al.  In vivo diffusion tensor imaging of the human optic nerve: Pilot study in normal controls , 2006, Magnetic resonance in medicine.

[6]  F. Fitzke,et al.  Scaling the hill of vision: the physiological relationship between light sensitivity and ganglion cell numbers. , 2000, Investigative ophthalmology & visual science.

[7]  Douglas R. Anderson,et al.  Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. , 1998, American journal of ophthalmology.

[8]  D E Gaasterland,et al.  The Advanced Glaucoma Intervention Study (AGIS): 1. Study design and methods and baseline characteristics of study patients. , 1994, Controlled clinical trials.

[9]  N. Gupta,et al.  Glaucoma as a neurodegenerative disease , 2007, Current opinion in ophthalmology.

[10]  Douglas R. Anderson,et al.  Clinical Decisions In Glaucoma , 1993 .

[11]  N. Gupta,et al.  Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex , 2006, British Journal of Ophthalmology.

[12]  M. Kass,et al.  The Ocular Hypertension Treatment Study: design and baseline description of the participants. , 1999, Archives of ophthalmology.

[13]  Serge Resnikoff,et al.  Global magnitude of visual impairment caused by uncorrected refractive errors in 2004. , 2008, Bulletin of the World Health Organization.

[14]  B. Prum,et al.  The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deterioration , 2000 .

[15]  P. V. van Zijl,et al.  Three‐dimensional tracking of axonal projections in the brain by magnetic resonance imaging , 1999, Annals of neurology.

[16]  P. Kaufman,et al.  Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma. , 2000, Archives of ophthalmology.

[17]  M. C. Leske,et al.  Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. , 2002, Archives of ophthalmology.

[18]  G. Holder,et al.  Relationship between electrophysiological, psychophysical, and anatomical measurements in glaucoma. , 2002, Investigative ophthalmology & visual science.

[19]  Gareth J. Barker,et al.  Optic nerve diffusion tensor imaging in optic neuritis , 2006, NeuroImage.

[20]  P. Khong,et al.  The Evaluation of Wallerian Degeneration in Chronic Paediatric Middle Cerebral Artery Infarction Using Diffusion Tensor MR Imaging , 2004, Cerebrovascular Diseases.

[21]  H. Quigley,et al.  The number of people with glaucoma worldwide in 2010 and 2020 , 2006, British Journal of Ophthalmology.

[22]  R S Harwerth,et al.  Ganglion cell losses underlying visual field defects from experimental glaucoma. , 1999, Investigative ophthalmology & visual science.

[23]  N. Gupta,et al.  What changes can we expect in the brain of glaucoma patients? , 2007, Survey of ophthalmology.

[24]  K Togashi,et al.  Diffusion tensor fiber tractography of the optic radiation: analysis with 6-, 12-, 40-, and 81-directional motion-probing gradients, a preliminary study. , 2007, AJNR. American journal of neuroradiology.

[25]  Earl L. Smith,et al.  Neural losses correlated with visual losses in clinical perimetry. , 2004, Investigative ophthalmology & visual science.

[26]  A Heijl,et al.  Early Manifest Glaucoma Trial: design and baseline data. , 1999, Ophthalmology.

[27]  J Katz,et al.  Reliability indexes of automated perimetric tests. , 1988, Archives of ophthalmology.

[28]  H. Quigley Number of people with glaucoma worldwide. , 1996, The British journal of ophthalmology.

[29]  P. Lichter,et al.  The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. , 1999, Ophthalmology.